FDA Inspection 1303280 — ADMA BioCenters Georgia Inc
The FDA completed an inspection of ADMA BioCenters Georgia Inc on Feb 6, 2026 in Greensboro, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 6, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Greensboro, NC (United States)